Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 134 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ResMed Inc | RMD | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.26 | 0.68% | 185.48 | 04:53:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 184.22 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 134 | - | 132.24 - 243.52 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:52:52 | formt | 134 | $ 185.48 | USD |
ResMed (RMD) Options Flow Summary
ResMed Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 27.1B | 147.09M | - | 4.22B | 897.56M | 6.10 | 30.19 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ResMed News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 182.00 | 184.83 | 172.19 | 177.80 | 1,662,264 | 3.48 | 1.91% |
| 1 Month | 195.49 | 198.535 | 172.19 | 184.41 | 1,060,241 | -10.01 | -5.12% |
| 3 Months | 192.31 | 198.535 | 170.56 | 186.03 | 1,011,611 | -6.83 | -3.55% |
| 6 Months | 144.98 | 198.535 | 132.24 | 171.76 | 1,065,376 | 40.50 | 27.93% |
| 1 Year | 228.00 | 243.52 | 132.24 | 173.93 | 1,108,309 | -42.52 | -18.65% |
| 3 Years | 209.71 | 301.34 | 132.24 | 202.90 | 743,072 | -24.23 | -11.55% |
| 5 Years | 101.44 | 301.34 | 100.94 | 189.20 | 685,926 | 84.04 | 82.85% |
ResMed Description
| ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting. |
